Analytical Data
-
基因名
SBDS
- Application
-
别名
SBDS;Ribosome maturation Protein SBDS
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9Y3A5
-
表达区间
1-250aa
-
氨基酸序列
MGSSHHHHHHSSGLVPRGSHMSIFTPTNQIRLTNVAVVRMKRAGKRFEIA CYKNKVVGWRSGVEKDLDEVLQTHSVFVNVSKGQVAKKEDLISAFGTDDQ TEICKQILTKGEVQVSDKERHTQLEQMFRDIATIVADKCVNPETKRPYTV ILIERAMKDIHYSVKTNKSTKQQALEVIKQLKEKMKIERAHMRLRFILPV NEGKKLKEKLKPLIKVIESEDYGQQLEIVCLIDPGCFREIDELIKKETKG KGSLEVLNLKDVEEGDEKFE
-
分子量
31 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of SBDS (Shwachman-Diamond syndrome protein) and its role as a recombinant protein has gained significant attention due to its association with Shwachman-Diamond syndrome (SDS), a rare genetic disorder characterized by exocrine pancreatic insufficiency, hematological abnormalities, and increased cancer predisposition. The SBDS gene, located on chromosome 7, encodes a protein involved in ribosome biogenesis and cellular stress response. Mutations in the SBDS gene disrupt these critical processes, leading to the clinical manifestations of SDS. Research on SBDS recombinant protein offers insights into the molecular mechanisms underlying the disease, facilitating the development of potential therapeutic strategies. Recombinant SBDS can be utilized in various experiments to elucidate its structure, function, and interactions with other cellular components. By understanding how SBDS operates at a cellular level, researchers aim to uncover pathways that could be targeted for treatment, improving patient outcomes for those affected by SDS. Furthermore, studying SBDS as a recombinant protein also allows for the exploration of potential roles in other diseases, given its involvement in ribosome assembly and cellular homeostasis. Ultimately, the insights gained from SBDS research hold promise not only for advancing our knowledge of Shwachman-Diamond syndrome but also for enhancing our understanding of fundamental biological processes relevant to a broader spectrum of diseases.












